KX2-391 dihydrochloride
Catalog No.
A3535
Src kinase inhibitor
Featured Products
KX2-391 is an orally bioavailable small molecule Src kinase inhibitor with potential antineoplastic activity. Unlike other Src kinase inhibitors which bind to the ATP-binding site, Src kinase inhibitor KX2-391 specifically binds to the peptide substrate binding site of Src kinase; inhibition of kinase activity may result in the inhibition of primary tumor growth and the suppression of metastasis. Src tyrosine kinases are upregulated in many tumor cells and play important roles in tumor cell proliferation and metastasis.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 504.45 |
Cas No. | 1038395-65-1 |
Formula | C26H31Cl2N3O3 |
Synonyms | KX2-391 2HCl; KX2-391 |
Solubility | ≥25.2 mg/mL in DMSO; insoluble in H2O; ≥48.8 mg/mL in EtOH with gentle warming |
Chemical Name | N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide;dihydrochloride |
SDF | Download SDF |
Canonical SMILES | C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4.Cl.Cl |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
-
Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
